Beger HG - Search Results

1

Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features.

Hatzitheoklitos E, Büchler MW, Friess H, Poch B, Ebert M, Mohr W, Imaizumi T, Beger HG. Hatzitheoklitos E, et al. Among authors: beger hg. Cancer. 1994 Mar 15;73(6):1580-8. doi: 10.1002/1097-0142(19940315)73:6<1580::aid-cncr2820730608>3.0.co;2-0. Cancer. 1994. PMID: 8156484 Review.

2

Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis.

Büchler MW, Friess H, Müller MW, Wheatley AM, Beger HG. Büchler MW, et al. Among authors: beger hg. Am J Surg. 1995 Jan;169(1):65-9; discussion 69-70. doi: 10.1016/s0002-9610(99)80111-1. Am J Surg. 1995. PMID: 7818000 Clinical Trial.

3

Role of octreotide in the treatment of pancreatic cancer.

Ebert M, Friess H, Beger HG, Büchler MW. Ebert M, et al. Among authors: beger hg. Digestion. 1994;55 Suppl 1:48-51. doi: 10.1159/000201189. Digestion. 1994. PMID: 8132137 Clinical Trial.

4

The risk of pancreaticointestinal anastomosis can be predicted preoperatively.

Friess H, Malfertheiner P, Isenmann R, Kühne H, Beger HG, Büchler MW. Friess H, et al. Among authors: beger hg. Pancreas. 1996 Aug;13(2):202-8. Pancreas. 1996. PMID: 8829190

5

Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.

Gansauge F, Gansauge S, Rau B, Scheiblich A, Poch B, Schoenberg MH, Beger HG. Gansauge F, et al. Among authors: beger hg. Cancer. 1997 Nov 1;80(9):1733-9. doi: 10.1002/(sici)1097-0142(19971101)80:9<1733::aid-cncr6>3.0.co;2-f. Cancer. 1997. PMID: 9351541

6

A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma?

Büchler M, Malfertheiner P, Baczako K, Krautzberger W, Beger HG. Büchler M, et al. Among authors: beger hg. Digestion. 1985;31(1):54-9. doi: 10.1159/000199178. Digestion. 1985. PMID: 2858422

7

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.

Friess H, Langhans J, Ebert M, Beger HG, Stollfuss J, Reske SN, Büchler MW. Friess H, et al. Among authors: beger hg. Gut. 1995 May;36(5):771-7. doi: 10.1136/gut.36.5.771. Gut. 1995. PMID: 7797130 Free PMC article.

8

CA 494--a new tumor marker for the diagnosis of pancreatic cancer.

Friess H, Büchler M, Auerbach B, Weber A, Malfertheiner P, Hammer K, Madry N, Greiner S, Bosslet K, Beger HG. Friess H, et al. Among authors: beger hg. Int J Cancer. 1993 Mar 12;53(5):759-63. doi: 10.1002/ijc.2910530509. Int J Cancer. 1993. PMID: 8449599

9

Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.

Friess H, Beger HG, Kunz J, Funk N, Schilling M, Büchler MW. Friess H, et al. Among authors: beger hg. Anticancer Res. 1996 Mar-Apr;16(2):915-20. Anticancer Res. 1996. PMID: 8687151

10

CAM 17.1--a new diagnostic marker in pancreatic cancer.

Gansauge F, Gansauge S, Parker N, Beger MI, Poch B, Link KH, Safi F, Beger HG. Gansauge F, et al. Among authors: beger hg, beger mi. Br J Cancer. 1996 Dec;74(12):1997-2002. doi: 10.1038/bjc.1996.666. Br J Cancer. 1996. PMID: 8980403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters